Login / Signup
Alvaro Carvallo
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Replacement Therapy
Tyrosine Kinase
Top Venues
Allergy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Alvaro Carvallo
,
Sergio Sánchez-Fernández
,
María de la Paz Morales-Palacios
Fenebrutinib and BTK inhibition: Unveiling a new target for the treatment of chronic spontaneous urticaria.
Allergy
(2022)